$1.59 Billion is the total value of Slate Path Capital LP's 13 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 53.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSO | Buy | TESORO CORP | $246,939,000 | +83.0% | 2,705,000 | +49.0% | 15.56% | +64.8% |
| KRFT | New | KRAFT FOODS GROUP INC | $212,996,000 | – | 2,445,000 | +100.0% | 13.42% | – |
| GOLD | Buy | BARRICK GOLD CORP | $182,484,000 | +328.1% | 16,650,000 | +319.9% | 11.50% | +285.6% |
| CHTR | CHARTER COMMUNICATIONS INC Dcl a new | $175,730,000 | +15.9% | 910,000 | 0.0% | 11.07% | +4.4% | |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $155,811,000 | -8.9% | 1,840,000 | -18.0% | 9.82% | -18.0% |
| TRCO | Sell | TRIBUNE MEDIA COcl a | $108,546,000 | -33.1% | 1,785,000 | -34.3% | 6.84% | -39.7% |
| MPC | Sell | MARATHON PETE CORP | $92,151,000 | -16.0% | 900,000 | -25.9% | 5.81% | -24.3% |
| IPXL | Sell | IMPAX LABORATORIES INC | $90,693,000 | +22.9% | 1,935,000 | -17.0% | 5.72% | +10.7% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $89,279,000 | +7.6% | 855,000 | 0.0% | 5.63% | -3.0% | |
| ZNGA | ZYNGA INCcl a | $74,499,000 | +7.1% | 26,140,000 | 0.0% | 4.70% | -3.5% | |
| PODD | New | INSULET CORP | $71,036,000 | – | 2,130,000 | +100.0% | 4.48% | – |
| CDK | New | CDK GLOBAL INC | $46,760,000 | – | 1,000,000 | +100.0% | 2.95% | – |
| YOKU | YOUKU TUDOU INCsponsored adr | $39,875,000 | -29.8% | 3,190,000 | 0.0% | 2.51% | -36.8% | |
| AIG | Exit | AMERICAN INTL GROUP INC | $0 | – | -340,000 | -100.0% | -1.33% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -689,455 | -100.0% | -1.34% | – |
| P | Exit | PANDORA MEDIA INC | $0 | – | -5,656,054 | -100.0% | -7.06% | – |
| SIRI | Exit | SIRIUS XM HLDGS INC | $0 | – | -33,010,000 | -100.0% | -8.08% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -1,000,000 | -100.0% | -8.37% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.